Literature DB >> 8431502

Quantification and kinetics of 25-hydroxyvitamin D3 by isotope dilution liquid chromatography/thermospray mass spectrometry.

D Vicchio1, A Yergey, K O'Brien, L Allen, R Ray, M Holick.   

Abstract

A liquid chromatography/thermospray mass spectrometry method has been developed and used to measure the plasma levels and half-life of 25-hydroxyvitamin D3 in adults. The mean plasma levels of 25-hydroxyvitamin D3 averaged 40 ng ml-1 (n = 4) in summer and 30 ng ml-1 (n = 6) in winter. The method was also used to determine the half-life of serum 25-hydroxyvitamin D3 in subjects maintained on either high or low-fiber diets who had been given an intravenous infusion of (6,19,19-2H3)25-hydroxyvitamin D3 sufficient to label 5% of their estimated body pools. The half-life was determined to be 10.4 days (n = 4), which is approximately 50% of the currently accepted value of 19 days, determined using radiolabeled methods. This difference may be due to kinetic isotope effects arising as a result of the tritiated compounds being labeled at sites that undergo Cyt-P450-catalyzed oxidations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431502     DOI: 10.1002/bms.1200220107

Source DB:  PubMed          Journal:  Biol Mass Spectrom        ISSN: 1052-9306


  7 in total

1.  Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults.

Authors:  Kerry S Jones; Inez Schoenmakers; Les J C Bluck; Shujing Ding; Ann Prentice
Journal:  Br J Nutr       Date:  2011-09-07       Impact factor: 3.718

2.  Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.

Authors:  Zhican Wang; Yvonne S Lin; Leslie J Dickmann; Emma-Jane Poulton; David L Eaton; Johanna W Lampe; Danny D Shen; Connie L Davis; Margaret C Shuhart; Kenneth E Thummel
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

3.  Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK.

Authors:  K S Jones; S Assar; D Vanderschueren; R Bouillon; A Prentice; I Schoenmakers
Journal:  Osteoporos Int       Date:  2014-10-03       Impact factor: 4.507

4.  Novel CYP27B1 Gene Mutations in Patients with Vitamin D-Dependent Rickets Type 1A.

Authors:  Korcan Demir; Walaa E Kattan; Minjing Zou; Erdem Durmaz; Huda BinEssa; Özlem Nalbantoğlu; Roua A Al-Rijjal; Brian Meyer; Behzat Özkan; Yufei Shi
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 5.  Osteoporosis in chronic obstructive pulmonary disease.

Authors:  Malay Sarkar; Rajeev Bhardwaj; Irappa Madabhavi; Jasmin Khatana
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-03-12

6.  Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections-Sepsis and COVID-19.

Authors:  Sunil J Wimalawansa
Journal:  Nutrients       Date:  2022-07-21       Impact factor: 6.706

7.  25-OH-Vitamin D and procalcitonin levels after correction of acute hyperglycemia.

Authors:  Nalan Metin Aksu; Duygu Yazgan Aksoy; Meltem Akkaş; Hakkı Yilmaz; Canan Akman; Bülent Okan Yildiz; Mahir M Ozmen; Aydan Usman
Journal:  Med Sci Monit       Date:  2013-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.